Red Abbey Venture Partners

Red Abbey Venture Partners is a life sciences investment firm that was founded in 2004. Since that time, we have invested in 14 privately held and 9 publicly traded life sciences companies. Our mission is to generate superior, risk-adjusted returns by investing in young companies that are developing the next generation of drugs and devices, as well as companies that are supporting these efforts with novel tools and products. Specifically, we are seeking to invest across the life sciences spectrum, which includes biotechnology, specialty pharmaceutical, medical device, diagnostics and research tools companies.

We believe that the life sciences sector has retained an “innovative edge” and that these companies will help people lead longer, healthier, more productive lives.

As such, we are:
      1) Targeting important diseases where the upside of success is significant;
      2) Investing in companies with a unique combination of high quality management and technology.

Our investment team and advisors are a multi-faceted group of individuals who possess a deep network of relationships. Furthermore, our experience in all aspects of these companies – scientific, financial, operational – provides us with the ability to conduct exceptional due diligence and add meaningful value to our portfolio companies.

HISTORY

Red Abbey Venture Partners is the second generation of a life sciences investment program that Frank A. Bonsal, Jr. and Philip Goelet, PhD began in 1997 with an investment in RiboTargets Holdings, PLC. From 1997 to the formation of Red Abbey Venture Partners in 2004, Mr. Bonsal and Dr. Goelet invested in 14 life sciences companies.